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BACKGROUND
Type  2  diabetes  is  known  to  be  associated  with  an  excessively  high  rate  of 
morbidity  and  mortality  from macrovascular  disease  1.This  increased  risk  has  been 
attributed  to  high  prevalence  of  multiple  atherosclerotic  risk  factors  among diabetic 
patients.
Recently, “Inflammation” and “Inflammatory” cytokines have been postulated to 
be important pathogenic factors in the development of insulin resistance and Type 2 
diabetes  3,  4.  CRP,  a  non-specific  marker  of  the  inflammatory  response,  is  most 
consistently  associated  with  the  development  of  Type  2  diabetes,  (5,  6)  however,  a 
casual association remains unproven. CRP and interleukin-6 (IL-6) are associated with 
the risk of CHD and severity of atherosclerosis (7, 8). Whether these molecules play a 
causative role, or simply act as markers of the acute-phase reaction, is debatable. The 
molecular  basis  for  the link between inflammation and diabetes likely relates  to the 
action  of  cytokines  such  as  IL-6  and  TNF-α,  which  includes  insulin  resistance  and 
stimulates the acute phase inflammatory response (9). The macrovascular complications 
are  essentially  due  to  accelerated  atherosclerosis  because  of  endothelial  dysfunction 
linked to hyperglycemia and other factors setting up pro-atherogenic pattern (10). A non-
invasive and relatively inexpensive investigation for identifying atherosclerosis, even in 
an asymptomatic patient, is measurement of IMT of the extra cranial carotid arteries by 
Doppler ultrasound. Endothelial dysfunction is an early functional marker and IMT an 
early morphological parameter of atherosclerosis (11).
Ethnic differences in CHD morbidity and mortality (12), in the prevalence and 
course of type 2 diabetes (13) and in carotid IMT have been reported (14). Asian Indians 
have a high risk of diabetes and have an obesity phenotype characterized by lean BMI, 
central  obesity  and high body fat  percentage.  Also they have high degree of insulin 
resistance (15). The increased predisposition of certain population of type 2 diabetes 
raises important question and emphasize the need for studies on inflammatory markers, 
insulin resistance, IMT and its determinants in different populations.
The basic pathophysiology underlying macrovascular disease is atherosclerosis. 
The word atherosclerosis is of Greek origin and literally means focal accumulation of 
lipid (ie. athero [porridge]) and thickening of intima (ie. sclerosis [hardening]) (2). It is 
basically a disease of large and medium sized muscular arteries and is characterized by 
endothelial  dysfunction,  vascular  inflammation  and  build  up  of  lipids,  cholesterol, 
calcium and cellular debris within the intima of the vessel wall. This result in plaque 
formation, vascular remodeling, acute and chronic luminal obstruction, abnormalities of 
blood flow and diminished oxygen supply to target organs (3).
A complex and incompletely understood interaction exists between the critical 
cellular elements of the atherosclerotic lesion. These cellular elements are endothelial 
cells,  smooth  muscle  cells,  platelets  and  leucocytes.  Vasomotor  function,  the 
thrombogenecity  of  the  blood vessel  wall,  the  state  of  activation  of  the  coagulation 
cascade,  the fibrinolytic  system,  smooth muscle  cell  migration and proliferation and 
cellular inflammation are complex and interrelated biological process that contribute to 
atherogenesis  and  clinical  manifestations  of  atherosclerosis  (6).  A large  number  of 
growth factors, cytokines and vasoregulatory molecules participate in this process (5).
The  mechanism  of  atherogenesis  remains  uncertain.  The  “response-to-injury” 
theory is most widely accepted. Endothelial injury causes vascular inflammation and a 
fibro proliferative response ensues (3).  Probable causes of  endothelial  injury include 
LDL cholesterol, infectious agents, toxins, including by products of cigarette smoking, 
hyperglycemia  and  hyperhomocysteinemia  (2).  Type  2  diabetes  mellitus  related 
macrovascular  complications  are  primarily  attributed  to  endothelial  dysfunction  and 
dyslipedemia. Circulating monocytes infiltrate the intima of the vessel wall and these 
tissue macrophages act as scavenger cells, taking up LDL and forming the characteristic 
foam  cell  of  early  atherosclerosis.  These  activated  macrophages  produce  numerous 
factors that are injurious to endothelium (4).
The  carotid  arteries  can  be  well  visualized  by  ultrasonography  and 
ultrasonographic  measurements of  the thickness  of  carotid  intima media  wall  (IMT) 
have been investigated as a technique to identify and monitor subclinical atherosclerosis. 
B mode ultrasound is most commonly used and the intima media thickness is measured 
and averaged over six sites in each carotid artery.
As India has been predicted to be the world’s capital for diabetes mellitus and 
coronary artery disease more data  availability  for  Indian population becomes all  the 
more  crucial.  We  thus  are  doing  a  comparative  study  and  intend  to  get  a  positive 
correlation between the two so that Doppler can be taken as a non-invasive investigative 
modality in individuals at high risk. If found significant  we can predict  the increase 
likelihood  of  these  patients  to  develop  a  coronary  event  and  take  measures  for 
preventing the same.
                        REVIEW OF LITERATURE
At the beginning of the 20th century, cardiovascular diseases (CVD) accounted for 
<10% of all the deaths worldwide. At its end, CVD accounted for nearly the deaths in 
the developed countries and 25% in developing world (8). By 2020, CVD will claim 25 
million deaths annually and CHD will surpass infectious diseases as the world’s number 
one cause of death.
This global rise in CVD, is the result of a dramatic shift in the health status of 
individuals around the world over the course of the 20th century. Before 1990, infectious 
diseases and malnutrition were the most common causes of death. These have gradually 
supplanted in (mostly developed) countries by chronic diseases such as CVD and cancer. 
Thanks largely to nutrition and public health measures. As this trend spreads to and 
continues in developing countries, CVD will dominate as the major cause of death by 
2020, accounting for at least one in every three deaths (9).
The  basic  pathogenic  mechanism  underlying  macro  vascular  disease  is 
atherosclerosis  of  the  vascular  tree  and  endothelial  dysfunction.  The  concept  of 
endothelial  dysfunction  has  been  around  for  a  number  of  years.  Many  researchers 
promote the notion that endothelial dysfunction is likely to be a critical early step in the 
process of atherogenesis. 
Endothelial dysfunction in diabetes
There is now an ample evidence from studies that endothelial dysfunction occurs 
in  type 2 diabetes  including elevation of  FFAs,  characteristic  lipid changes,  obesity, 
hyper tension and low grade inflammation (Tooke and Goh, 1999, Hink et al 2001) 
Understanding the pathogenesis of atherosclerosis firsts requires knowledge of the 
structure and biology of the normal artery and its indigenous cell types.
Normal arteries have a well developed trilaminar structure. The innermost layer is 
the tunica intima which is thin at birth in humans and many non human species.
A monolayer of endothelial cells lines the intimal surface of the entire circulatory 
tree, thereby representing the only stationary cell type that components of blood ever 
come in contact with under normal circumstances. The endothelial surface of the adult 
human is enormous. It is composed of about (1 to 6 x 10^13) cells, weighs about 1 kg 
and covers a surface area equivalent to six tennis courts (10).
Today, we recognize that endothelium is a dynamic organ with complex metabolic 
capabilities,  including  the  ability  to  control  vascular  permeability,  the  flow  of 
biologically active molecules and nutrients,  cell  – cell  and cell  – matrix interactions 
within the vessel wall,  blood flow and vascular tone, interactions of blood cells,  the 
inflammatory response and angiogenesis.
A delicate balance exists in the capability of the endothelial  cells to modulate 
vascular tone. An important physiological vasodilator released by endothelial cells is 
nitrous oxide, thus significance of nitric oxide in antiatherogenesis (26). It is a simple 
diatomic gas synthesized from the terminal guanidine nitrogen atoms of L arginine by 
the action of a group of enzymes known as nitric oxide synthases (NOS) [ Vans etal,  
1990;  Monacada  &  Higgs,  1993]  (11,12).  The  major  iso  form  of  NOS  present  in 
endothelial  cells,  eNOS, is  constitutively active and further  activated by stimuli  that 
increase  intracellular  calcium  including  several  receptor  dependant  agonists  (e.g. 
Thrombin)  and hemodynamic  forces  (shear  stress  and  cyclic  stretch).  NO acts  as  a 
potent vasodilator and adhesion by stimulating soluble guanylate cyclase and thereby 
elevates intra cellular levels of cGMP in vascular smooth muscle cells and platelets. 
Prostaglandin  12  (PG12,  Prostacyclin)  is  a  major  endothelium derived  oxygenation 
product  of  arachidonic  acid,  synthesized  by  the  sequential  actions  of  cycloxygenase 
(COX) and Prostacylin synthase (13). Prostacyclin like NO is both a vasodilator and 
inhibitor of platelet aggregation (not adhesion); exerting these actions by stimulating 
adenylate cyclase and thus the intracellular  CAMP in target  vascular smooth muscle 
cells and platelets.
Endothelium derived hyperpolarizing factor (EDHF) and carbon monoxide (CO) a 
by-product  of  heme  metabolism  to  biliverdin  by  heme  oxygenases  are  the  direct 
vasodilators elaborated by endothelial cells. Endothelial ecto-adenosine diphosphatase 
(ADPase), recently identified as CD39, is a membrane associated platelet inhibitor but 
may  also  indirectly  promote  vasodilation  by  generating  adenosine.  The  vasodilatory 
properties  of  endothelium  are  counter  balanced  by  endothelium  –  derived 
vasoconstrictors, including platelet activating factor, endothelin-1 and thromboxane A2 
(TXA2)
Vaso regulation by endothelium
Nitric Oxide PAF
PGI2 (Prostacyclin) Endothelin-1
Others – EDHF Others – TxA2
Carbon monoxide, ADPase
Vasodilatation Vasoconstriction
Endothelium is also an ideal regulator of hemostasis (14). It is endowed with a 
remarkable  repertoire  of  activities  that  permit  it  to  rapidly  transform from a  potent 
antithrombotic to a prothrombotic surface whenever the need arises. Normal quiescent 
endothelium constitutively displays a potent antithrombotic (thromboresistant) surface to 
blood.  It  expresses  anticoagulant,  profibrinolytic  and  platelet  inhibitory  properties 
whenever endothelium is activated or perturbed, however, it is rapidly transformed to a 
prothrombotic  surface  that  actually  promotes  coagulation,  inhibits  fibrinolysis  and 
activates platelets. Throughout the circulatory tree, even within a single organ, there is 
marked  heterogeneity  in  the  phenotype  of  endothelial  cells  (15,16)  with  respect  to 
hemostasis,  for  e.g. Endothelial  cells from different  tissues are heterogenous in their 
expressions  of  vWF,  plasminogen  activators  and  tissue  factor.  This  endothelial 
heterogeneity is maintained by both genetic and environmental factors.
The specific antithrombotic and prothrombotic properties of endothelial Cells are 
as follows:-
Regulation of Hemostasis by Endothelium
Anticoagulant :
• GAGs/AT III
• TFPI
• Thrombomodulin
Procoagulant :
• Tissue factor
• Binding  sites  for  Coagulation  factors 
and fibrin
Profibrinolytic:
• t-PA
• u-PA
• Binding  sites  for 
Plasminogen
• PA receptors
Antifibrionolytic:
• PAI
• TAFI
Platelet inhibitory :
• PGI2 ( Prostacyclin)
• Nitric Oxide
• AD Pase
• Carbon monoxide
Platelet activating:
• vWF
• PAF
GAgGs - lycosaminoglycans
AT III - Antithrombin III,
TFPI - Tissue factor pathway inhibitor,
t-PA - Tissue plasminogen activator,
u-PA - Urokinase type plasminogen activator,
PAI - Plasminogen activator inhibitor,
VWF - Von Willibrand factor
PAF - Platelet activating factor
                The haemostatic conversion of the vessel wall is triggered by mechanical 
damage  or  by  perturbation  and  activation  of  the  vascular  cells  by  agents  such  as 
cytokines, endotoxin, hypoxia and hemodynamic forces.
In many cases, endothelium derived vasodilators are also platelet inhibitors and 
conversely, endothelium derived vasoconstrictors can also be platelet activators. The net 
effect of vasodilation and inhibition of platelet function is to promote blood fluidity, 
whereas the net effect of vasoconstriction & platelet activation is promote Hemostasis. 
Thus  blood  fluidity  and  Hemostasis  can  be  exquisitely  regulated  by  balance  of 
antithrombotic / prothrombotic & vasodilatory / vasoconstrictor properties of endothelial 
cells, which are often co-coordinately modulated by their relatives states of quiescence 
& activation (14),
‘’Endothelial  dysfunction’’  represents  a  pathophysiologic  state  in  which  the 
collective  homeostatic  properties  of  normal  endothelial  cells  are  impaired  or  lost, 
promoting an atherogenic milieu. Abnormalities in endothelial function are believed to 
play a central role in the pathophysiology of common cardiovascular syndromes such as 
myocardial infarction, unstable angina & stroke. It is associated with a growing number 
of  risk  factors  including  smoking,  diabetes  mellitus,  hypertension,  hyperlipidemia, 
hyperhomocystinemia, menopause & advanced age. Endothelial dysfunction is thought 
to presage atherosclerosis and is characterized by altered permeability barrier function, 
enhanced  adhesion  molecule  expression,  increased  leucocyte  adhesion  and  impaired 
endothelium dependent vasodilator responses {(Kupatt et al 1996) (Scalia et al 1996), 
(Penn et al 1997), (Rangasamy et al 1997)
Endothelial dysfunction is detectable very early in the progression of atherosclerosis, 
long  before  the  appearance  of  visible  of  visible  stenotic  lesions.  This  association 
suggests a biological link between endothelial dysfunction and vascular disease, thus 
making it an ideal target for primary preventive intervention.
The etiological factors associated with endothelial dysfunction are classical and 
novel risk factors.
Classical risk factors
1. Diabetes 
2. Hypertension 
3. Smoking 
4. Dyslipidemia
Novel risk factors are
5. Low grade chronic inflammation: 
6. Obesity
7. Leptin 
8. Homocysteine
9. Low birth weight
10.Ethnicity 
Plasma Markers of Endothelial cell Function (25)
Markers for which clinical data are available
• Fibrinolytic substances
 Plasminogen activators
 Plasminogen activator inhibitor-1
• Procoagulant substances
 vWF
 Fibronectin
• Antiplatelet substances
 Nitric Oxide
 Prostacylin
• Metabolic substances
 Lipoprotein lipase
• Potential markers
 Activated protein C
 Antithrombin III
 Angiotensin – Converting enzyme
 Heparan sulphate
 Laminin
 Thrombospondin
 Tissue factor
 Vittonecti
NORMAL VERSUS DYSFUNCTIONAL ENDOTHELIAL CELL (24)
(N) Endothelial Cell Dysfunctional endothelial cell
PGI2 Production Decreased PGI2 Production
EDRF release Decreased DERF release
Ecto – ADT pase activity Increased thromboplastin Production
Facilitation  of  vascular  uptake  & 
degradation of prothrombotic amines
Inhibition of endothelial cell – 
dependent protein C activation
Thrombin  binding & inactivation Decreased resistance to platelet adhesion
Thrombomodulin expression Increased PAI-1 release
Glycosamino glycan expression Impaired thrombomodulin expression
Tissue factor expression
Clinical  assessment  of  endothelium represents  a  challenging  task  owing to  its 
heterogeneous  functions.  No  single  test  provides  a  comprehensive  physiological 
assessment of endothelial function. Several makers as described above have been used 
an surrogate makers of endothelial activity and positively correlate with adverse cardio 
vascular  outcomes.  Most  clinical  studies  have  focused  primarily  or  regulation  of 
vascular tone as a means of assessing endothelial function (2) through interrogation of 
NO – mediated, endothelium – dependant vasodilator response to specific agonists, such 
as  acetyl  choline,  serotonin or  shear  actress  which normally  provoke vasodilatation. 
Paradoxical  constriction or  attenuated dilator  response are observed in disease states 
associated  with  atherosclerosis  or  risk  factors  for  coronary  artery  diseases  reflecting 
impaired vasomotor function & reduced endothelial NO bioactivity.
Because abnormal endothelial physiology is implicated in genesis and progression 
of vascular disease prevention or reversal of endothelial dysfunction respects attractive 
goal  for  therapeutic  intervention.  Indeed  reversal  interventions  have  been constantly 
shown  to  restore  endothelial  vasomotor  function.  These  include  among  other  lipid 
lowering therapy,  ACE inhibitor  therapy,  L-arginine tetra  hydrobiopterin,  folate,  anti 
oxidants  &  estrogen  supplementation,  smoking  cessation  and  exercise  (22,  23). 
Interesting  by these are  the very same interventions  that  attenuate  atherosclerosis  & 
improve  morbidity  & mortality  outcomes  from cardiovascular  diseases  suggesting  a 
mechanistic link between endothelial dysfunction & atherosclerosis.
The 
tunica media
It lies under the intima & internal elastic lamina. The media of elastic arteries such 
as aorta have well developed concentric layers of smooth muscle cells inter leaved with 
layers of  elastin rich extracellular  matrix.  This  structure appears well  adapted to the 
storage of kinetic energy of (Lt) ventricular systole by the walls of great arteries. The 
lamellar structure also contributes to the structural integrity of arterial trunks. The media 
of  smaller  muscular  arteries  usually  have  a  less  stereotyped  organization.  Smooth 
muscle cells in these arteries generally reside within the surrounding matrix in a more 
continuous  than  lamellary  array.  The  smooth  muscle  cells  in  normal  arteries  are 
generally quiescent from the standpoint of growth control. That is, rates of cell division 
and cell death are quite low in the normal artery; a state of homeostasis of extra cellular 
matrix  also typically  prevails.  Because extra  cellular  matrix  neither  accumulates nor 
 
atrophies,  rates  of  matrix  synthesis  and  dissolution  must  balance  each  other  under 
normal conditions.  The external elastic lamina bounds the tunica media,  forming the 
border with the adventitial layer.
The adventitia
The  adventitia  of  arteries  has  typically  received  little  attention,  although 
appreciation of its role in arterial homeostasis & pathology has recently increased. The 
adventitia  contains collagen fluids in  a  looser  array  than usually  encountered in  the 
intima Vasovasorum & nerve endings localize in this outermost layer of the arterial wall. 
The cellular population in the adventitia is more sparse than in other arterial layers. Cells 
encountered in this layer include fibroblasts in mast cells.
The initiation of atherosclerosis
The term atherosclerosis comes from the Greek work athero (porridge/gruel) and 
sclerosis (hardening).
Extracellular lipid accumulation
The first  steps in atherogenesis in human remain largely conjectural  However, 
integrations of tissues obtained from younger human with the results of experimental 
studies  of  atherogenesis  in  animal  provided hints  in  this  regard.  On initiation of  an 
atherogenic  diet  rich  cholesterol  and  saturated  fat,  one  of  the  first  ultra  structural 
alterations is an accumulation of small  lipoprotein particle in the intima (29). These 
lipoprotein particles appear to decorate the proteoglycan of the arterial intima and tend 
to coalesce into aggregates (30). The binding of lipoprotein to proteoglycan in the intima 
captures  and  retains  these  particles,  accounting  for  their  prolonged  residence  time. 
Lipoprotein particles bound to proteoglycan appear to exhibit increased susceptibility to 
oxidative  or  other  chemical  modifications,  considered  by  may  to  be  an  important 
component  of  pathogenesis  of  early  atherosclerosis.  Other  studies  suggest  that 
permeability of the endothelial monolayer increase at sites of lesion predilection to LDL 
(31). Contributors to oxidative stress in the nascent atheroma could include the NAD 
and NADP dependent oxidases exposed by vascular cells & lipooxygenases expressed 
by infiltration leucocytes. In addition of oxidation, aggregation, enzymatic processing 
due to sphingomyelinase & glycation can modify LDL in the intima.
Leukocyte Recruitment
The  second  morphologically  definable  event  in  the  initiation  of  atheroma  is 
leucocyte  recruitment  & accumulation.  The  normal  endothelial  cell  generally  resists 
adhesive interactions with leucocytes. Even in inflamed tissues, most recruitment and 
trafficking of leucocytes occurs in post capillary venules, not in arteries. However, very 
early after initiation of hypercholesterolemia, leucocytes adhere to the endothelium & 
diapedese between endothelial cell functions to enter the intima, where they begun to 
accumulate  lipids  &  transform  into  foam  cells  (32).  In  addition  to  monocyte,  T-
lymphocytes also tend to accumulate in early human & animal atherosclerotic lesions 
(33).
The expression of certain leucocyte adhesions molecules on the surface of the 
endothelial cells regulates the adherence of monocytes & T cells to the endothelium. 
Two  broad  categories  of  leucocyte  adhesion  molecules  exist.  Members  of  the 
immunoglobulin superfamily include structures such as vascular adhesion molecules 1 
(VCAM-1) (34). This adhesion molecules has particular interest in the context of early 
atherosclerosis  because  it  interacts  with  an  integrin  (very  late  antigen  –  4  [VLA-4] 
characteristically  expressed  by  only  those  classes  of  leucocytes  that  accumulate  in 
nascent  atheroma,  monocytes  and T cells  moreover,  studies  in  rabbits  & mice  have 
shown expression of VCAM-1 on endothelial cells overlying very early atheromatous 
lesions.  Another member  of the immunoglobulin super family of leucocyte adhesion 
molecules in intercellular adhesion molecule -1. This molecule is more promiscuous, 
both in the types of leucocytes it binds and because of its wide & constitutive expression 
at low levels by endothelial cells in many parts of the circulation. Selectin, constitute the 
other  broad category  of  leucocyte  adhesion  molecules.  The prototypical  selectin,  E-
Selectin  (E-for  ‘’Endothelial’’,  the cell  type that  selectively  expresses  this  particular 
family  member).  Probably  has  little  to  do  with  early  atherogenesis.  E-selection 
preferentially recruits polymorphonuclear leucocytes, a cell type seldom found in early 
atheroma (but an essential protagonist in acute inflammation & host defenses against 
bacterial  pathogens).  Moreover,  endothelial  cells  overlying  atheroma do  not  express 
high  levels  of  this  adhesion  molecule.  Other  members  of  this  family,  including  P-
selection,  may  play  a  greater  role  in  leucocyte  recruitment  in  atheroma,  because 
endothelial  cells  overlying  human  atheroma  do  express  this  adhesion  molecule. 
Selections  tend  to  promote  saltatory  or  rolling  locomotion  of  leucocytes  over  the 
endothelium (35). Adhesion molecules belonging to the immunoglobulin super family 
tend to promote trigger adhesive interaction & immobility action of leucocytes.
Once adherent to the endothelium, leucocytes must receive signal to penetrate the 
endothelium & enter the arterial wall. The migration of leucocytes involves action of 
protein molecules known as chemo attractants, cytokines or chemokines. Two groups of 
chemokines have particular interest in recruiting mononuclear cells characteristic of the 
early  atheroma.  One  such  molecule  known as  monocyte  chemo  attractant  protein-1 
(MCP-1)  is  produced  by  endothelium in  response  to  oxidized  lipoprotein  and  other 
stimuli. Cells intrinsic to the normal artery, including endothelium & smooth muscle, 
can  produce  this  chemokine  when  stimulated  by  inflammatory  mediators.  MCP-1, 
selectively  promotes  the  directed  migration  or  chemotaxis  of  monocytes.  Human 
atherosclerotic lesions expressed increased level MCP-1 as compared to other involved 
vessels.  Thus  MCP-1  appears  causally  related  to  monocyte  recruitment  during 
atherogenesis  in  vivo.  Another  group  of  chemo  attractant,  cytokines  may  attract 
lymphocyte accumulation in plaques. Atheromas express a trio of lymphocyte selective 
chemokines  (interferon-inducible  protein  10,  interferon  inducible  T-cell  &  chemo 
attractant,  I-TAC;  monokine  induced  by  interferon-gamma).  Interferon  gamma  a 
cytokine know to be present in the atheromatous plaques induces the gene encoding this 
family of T-cell chemo attractants.
Atheroma typically  forms  focally  as  revealed  by  studies  of  morphology,  lipid 
accumulation & adhesion molecule expression. Some have invoked a multicentric origin 
hypothesis of atherogenesis, pointing that atheromas arises a benign leiomyomas of the 
arterial wall. The monotypia of various molecular markers such a G6PD isoforms in 
individual atheromas supports this ‘’monoclonal theory of atherogenesis’’, However, the 
location of sites of lesion predilection at proximal portions of arteries after branch points 
or  bifurcation  at  flow  divides  suggests  a  hydrodynamic  basis  for  early  lesion 
development.  Arteries  without  many  branches  like  the  internal  mammary  or  radial 
arteries  tend  not  to  develop  atherosclerosis.
Two  concepts  can  help  understand  how local  flow  disturbances  might  render 
certain  foci  sites  of  lesion  predilection.  Locally  distributed  flow  could  induce 
alternations that promote the steps of early atherogenesis. Alternately, the laminar flow 
that  usually  prevails  at  sites  that  do  not  tend  to  develop  early  lesions  may  elicit 
antiatherogenic  homeostatic  mechanisms  (atheroprotective  function)  (36).  The 
endothelial cell experiences the laminar shear stress of normal flow and disturbed flow 
(usually yielding decreased shear stress) at predilection sites. This laminar shear stress 
can augment the expression of genes that may protect against atherosclerosis, including 
forms of enzymes superoxide dismutase & nitric oxide synthase.
Intercellular lipid accumulation: Foam cell formation
The monocyte, once recruited to the arterial intima, can there imbibe lipid and 
become a foam cell or lipid – laden macrophage. Whereas, most cells can express the 
classical  cell  surface  receptor  of  LDL,  that  receptor  does  not  mediate  foam  cell 
formation. This is evident clinically, because patients lacking functional LDL receptors 
(familial hypercholesterolemia homozygotes) still develop tedious xanthomas filled with 
foamy macrophages. The LDL receptor does not mediate foam cell formation because of 
its exquisite regulation by cholesterol. As soon as a cell collects enough cholesterol from 
LDL capture  for  its  metabolic  needs,  an  elegant  transcriptional  control  mechanism 
quenches expression of the receptor.
Instead  of  classical  LDL Receptor,  various  molecules  known as  ‘’scavenger’’ 
receptors  appears  to  mediate  the  excessive  lipid  uptake  characteristic  of  foam  cell 
formation (37). The long studies of these receptors belong to scavenger receptor – A 
family.  These  surface  molecules  bind  modified  rather  than  native  lipoproteins  & 
apparently  participate  in  their  internalization.  Other  receptors  that  bind  modified 
lipoprotein and that may participate in form cell formation include CD36 & macrosialin, 
the latter exhibiting preferential binding specificity for oxidized forms of LDL.
Once macrophages have taken up residence in the intima and become foam cells, 
they not infrequently replicate. These factors that trigger macrophage cell division in the 
atherosclerotic plaque likely include macrophage colony stimulating factor (M – CSF). 
This comitogen and survival factor for mononuclear phagocytes exists in human and 
experimental  atheromatous  lesion.  Other  candidates  for  macrophage  mitogens  / 
comitogens include interleukin-3 and granulocyte macrophage colony stimulating factor.
Thus,  the  scenario  of  the  evolving  atheroma  has  involved  only  leucocytes, 
principally  the  macrophages.  The  precursor  lesion,  known  as  fatty  streak,  consists 
mainly of accumulations of such lipid – engorged leucocytes. Fatty streaks may occur in 
children  and  in  societies  less  affected  by  atherosclerosis  pandemic  that  developed 
western nations. Moreover, in experimental animals withdrawal of the atherogenic diet 
and treatment with drugs that lower lipoprotein levels in plasma can reduce the extent of 
established lesions. Thus, fatty streaks, composed of primarily macrophages are likely 
reversible to some extent.
Further evolution of atheroma takes place as follows-
Smooth muscle cells migration & proliferation:
Whereas  the  early  events  in  atheroma  initiation  involves  primarily  altered 
endothelial  function and recruitment  and accumulation of  leucocytes,  the subsequent 
evolution of atheroma into a more complex plaque involves smooth muscle cells as well 
(38). Smooth muscle cells in the normal arterial tunica media differ considerably form 
those in the intima of an evolving atheroma. Although some smooth muscle cells arrive 
in the arterial intima, early in life, others that have arisen in the developing atheroma 
likely arise from cells  that  have migrated form the media to the intima.  The chemo 
attractants for  smooth muscle  cells likely include molecules such as platelet  derived 
growth  factor  a  potent  smooth  muscle  chemo  attractant  secreted  by  the  activated 
macrophages & over expressed in human atherosclerosis. These smooth muscle cells in 
atherosclerotic intima can also multiply be cell division. Estimated rates of division of 
smooth muscle cells in the atheromatous lesion are less than 1%. However, considerable 
smooth muscle cells accumulation can occur over decades of lesion evolution.
Smooth muscle cells in the atherosclerotic intima display a less mature phenotype 
than the quiescent smooth muscle cells in the normal arterial media layer. Instead of 
expressing isoforms of smooth muscle myosin characteristic of adult  smooth muscle 
cells, those in the intima have higher levels of embryonic isoform of smooth muscle 
myosin.  Thus smooth muscle  cells  in  the  intima seem to  recapitulate  an  embryonic 
phenotype. These intimal smooth muscle cells in the atheroma appear morphologically 
distinct as well. They contain more rough endoplasmic reticulum and fewer contractile 
fibers than do normal medial smooth muscle cells. Although replication of the smooth 
muscle cells in the steady state appears indolent in mature human atheromas, bursts of 
smooth muscle replication can occur during the life history of a given atheromatous 
lesion.  Accumulation  of  smooth  muscle  cells  during  atherosclerosis  and  growth  of 
intima may not occur in a continuous & linear fashion. Rather, ‘’Crisis’’ may punctuate 
the  history  of  an  atheroma  during  which  bursts  of  smooth  muscle  replication  and 
migration may occurs.
Smooth muscle cell death during angiogenesis
In  addition  to  smooth  muscle  cell  replication  death  of  these  cells  may  also 
participate in complication of the atherosclerotic plaque. At least some smooth muscle 
cells in advanced atheroma exhibit fragmentation of their nuclear DNA characteristic of 
programmed  cell  death  or  apoptosis  –  Apoptosis  may  occur  in  response  to  the 
inflammatory cytokines known to be present in the evolving atheroma. In addition to 
soluble cytokines that may trigger programmed cell death; the T cells in atheroma may 
participate  in  eliminating  some  smooth  muscle  cells,  In  particular,  some  T  cell 
populations known to accumulate in plaques can express fas ligand in their surface. Fas 
ligand can engage fas on the surface of the smooth muscle cells and in conjunction with 
pro inflammatory cytokines, lead to death of smooth muscle cells (39).
Thus,  smooth muscle cells  accumulation in the growing atherosclerotic plaque 
probably results from a tug-of-war between cell replication & cell death, Contemporary 
cell & molecular biological research has identified candidates for mediating both the 
replication  & attraction  of  smooth  muscle  cells,  a  concept  that  originated  from the 
careful, morphological observations of Virchow almost a century and half ago. Referring 
to  the  smooth  muscle  cells  in  the  intima,  Virchow  noted  that  early  atherosclerosis 
involves a ‘’multiplication of their nuclei’’ However, he recognized that cells in lesions 
can ‘’ hurry on to their own destruction’’ because of death of smooth muscle cells.
The arterial extracellular Matrix
Extracellular matrix rather than cells themselves makes up much of the volume of 
an  advanced  atherosclerotic  plaque.  Thus  extracellular  constituents  of  plaque  also 
require consideration. The major extracellular matrix macromolecules that accumulate in 
atheroma  include  intersitital  collagens  (types  I  &  III)  and  proteoglycans  such  as 
versican,  biglycan,  aggrecan  and  decorin.  Elastin  fibers  may  also  accumulate  in 
atherosclerotic  plaques.  The  vascular  smooth  muscle  cell  produces  these  matrix 
molecules in disease, just as it does during development & maintenance of the normal 
artery. Stimuli for excessive collagen production by smooth muscle cells include PDGF 
and Transforming growth factor – beta (TGF – B) both constituents of platelet granules 
& Products of many cell types found in lesion.
Much like the accumulation of smooth muscle cells, extracellular matrix secretion 
also depends on a balance.  In this case,  the biosynthesis of the extra cellular matrix 
molecules counters breakdown catalyzed in part by catabolic enzymes such as matrix 
metalloproteinases  (CMMPs),  Dissolution  of  extracellular  matrix  macromolecules 
undoubtedly plays a role in migration of smooth muscle cells as they penetrate in to the 
intima from the media through a dense extra cellular matrix, traversing the elastin-rich 
internal elastic lamina. In injured arteries, over expression of inhibitors of such proteins 
[known as tissue inhibitors of metalloproteinases (TIMP’s)] can delay smooth muscle 
accumulation in the intima (40).
Extracellular matrix dissolution also, likely plays a role in arterial remodeling that 
accompanies  lesion growth.  During the first  part  of  life,  history  of  an atheromatous 
lesion, growth of the plaque in outward in an ab luminal direction rather than inward in a 
way that would lead to luminal stenosis. This outward growth of the intima leads to an 
increase  in  caliber  of  the  entire  artery.  This  so  called  positive  remodeling  or 
compensatory  enlargement  must  involve  turnover  of  extra  cellular  matrix  molecules 
accommodate the circumferential growth of the arterial lumina. Stenosis tends to occur 
only after the plaque burden exceeds some 4% of the cross section of the artery.
Angiogenesis in plaque
The smooth muscle cells are not alone in its proliferation & migration within the 
involving  atherosclerotic  plaque.  Endothelial  migration  &  replication  also  occur  as 
plaques develop in microcirculation, characterized by plexus of newly formed vessels. 
Such  plaque  new  vessels  usually  require  special  stains  for  visualization.  However, 
histological examination with appropriate markers for endothelial cells reveals a rich 
neovascularisation in evolving plaques. These micro vessels likely form a response to 
angiogenic  peptides  over  expressed  in  atheroma.  This  angiogenesis  factors  include 
acidic & basic  fibroblast  growth factors (human BGF’s)  vascular  endothelial  growth 
factor (VEGF) and oncostain M (41),
These  micro  vessels  within  plaques  probably  have  considerable  functional 
significance. For example abundant micro vessels in plaques provide a relatively large 
surface for the trafficking of leucocytes. Indeed, in the advanced human atherosclerotic 
plaque  micro  vascular  endothelium  displaces  the  mononuclear  selective  adhesion 
molecules  such  as  VCAM-1  much  more  prominently  than  does  the  micro  vascular 
endothelium overlying  the  plaque.  The  microvascularity  of  plaques  may  also  allow 
growth of the plaque over coming diffusions, limitations of oxygen & nutrient supply in 
analogy with the concept of tumor angiogenic factors & growth of malignant lesions. 
Consistent  with  the  view  administration  of  inhibitors  of  angiogenesis  to  mice  with 
experimentally induced atheromas limits lesion expansions. Finally, the plaque micro 
vessels may be friable and prone to rupture like the new vessels in the diabetic retina. 
Haemorrahagic thrombosis in site could promote a local round of smooth muscle cell 
proliferation and matrix accumulation in the area immediately adjacent to the micro 
vascular disruption. This scenario illustrates a special case of one of the crises described 
earlier  in  the evolution of  the atheromatous plaque.  Attempt  to  augment  myocardial 
perfusion by enhancing new vessel growth by transfer of angiogenic proteins or their 
genes might have adverse effects on lesion growth or clinical complications of atheroma 
by these mechanisms.
Plaque mineralization
Plaque often develops areas of calcification as they evolve. Indeed both Virchow 
& Rokitansky recognized morphological  feature of bone formation in atherosclerotic 
plaques  in  early  microscopic  descriptions  of  atherosclerosis  (42).  In  recent  years, 
understanding of the mechanisms of mineralization during evolution of atherosclerotic 
plaques has advanced. Some subpopulations of smooth muscle cells may faster calcify 
by enhanced secretion of cytokines such as bone morphogenetic proteins, homologues of 
TGF-beta. Atheromatous plaques may also contain proteins with gamma carboxylated 
glutamic  acid  residues  specialize  in  sequestering  calcium  and  thus  promoting 
mineralization.
Composition of plaques
At autopsy, the atherosclerotic plaques of patients who died of MI is composed 
primarily  of  fibrous  tissues  of  varying  density  and  cellularity  with  superimposed 
thrombus. Calcium, lipid laden foam cells and extra cellular lipid each constitute 5-10% 
of the remaining area. The atherosclerotic plaques that are associated with thrombosis 
and total occlusion, located in infarct related vessels, are generally more complex and 
irregular  that  those  in  vessels  not  associated  with  MI.  Histological  studies  of  these 
lesions often reveal plaque rupture or erosion. Angiographic morphology suggestive of 
plaque rupture has been identified in the majority of stenosis associated with AMI or 
abrupt onset of unstable angina. This finding is rare in the non-infarct related vessels of 
patients with chronic stable angina.
Platelet  rich  thrombi  are  often  associated  with  the  surfaces  of  most  advanced 
atherosclerotic  lesions,  called  complicated  plaques,  which  are  characterized  by  fibro 
calcific  degeneration,  deposition  of  lipid,  calcium,  fibrous  tissue,  necrotic  debris, 
extravasated blood and fibrous cap. Lumina narrowing may potentiate platelet activation 
through augmentation of  shear  forces.  In  pts  with MI,  coronary thrombi  are  usually 
superimposed on or adjacent to atherosclerotic plaques. These coronary arterial thrombi, 
which are approximately 1 cm in length in most cases, adhere to the luminal surface of 
an  artery  and  are  compressed  of  platelets,  fibrin  erythrocytes  and  leucocytes.  The 
composition of the thrombus may vary at different levels; a white thrombus is composed 
of  platelets,  fibrin,  platelets  and  leucocytes.  Early  thrombi  are  usually  small  and 
nonocclusive and are composed predominantly of platelets.
Plaque fissuring and rupture
The process of plaque fissuring is an area of intensive investigation and is likely 
to be multi factorial in nature. In atherosclerotic plaques prone to rupture there is an 
increased rate of formation of metalloproteinase enzymes such as collagenase, gelatinase 
and stromelysin that degrades components of the protective interstitial  matrix. These 
proteinases may be elaborated by activated macrophages and mast cells that have been 
shown to accumulate in high concentrations at the site of atheromatous erosions and 
plaque  rupture  in  patients  who  died  of  AMI.  Examination  of  specimens  from 
atherectomy reveals a much higher content of macrophages and tissue factor in patients 
with unstable angina or AMI compared with patients with chronic stable angina.
 In addition to these structural aspects of vulnerable plaques, stress induced by 
intra  luminal  pressure,  coronary  vasomotor  tone,  tachycardia  (cyclic  stretching  and 
compression) and disruption of nutrient vessels combine to produce plaques rupture at 
margin of the fibrous cap near an adjacent plaque free segment of the coronary artery 
wall  (shoulder  region  of  plaque).  A number  of  key  physiological  variables  such  as 
systolic  blood  pressure,  heart  rate,  blood  viscosity,  endogenous  tissue,  plasminogen 
activator  activity,  (T-PA),  plasminogen activator  inhibitor  – 1 (PAI-1)  levels,  plasma 
cortisol  levels  and  plasma  epinephrine  levels  that  exhibit  circadian  and  seasonal 
variations and are increased at times of stress act in concert to produce a heightened 
propensity for plaque rupture and coronary thrombosis, yielding the clustering of AMI in 
early morning hours and especially in winter and after natural disasters.
Intimal – Medial Thickness (IMT)
An early  morphological  change  in  atherosclerosis  is  the  increase  of  the  IMT, 
which  can  be  detected  non  –  invasively  with  high  resolution  ultrasound  B  mode 
imaging.  In  early  stages  of  the  atherosclerotic  process,  the  vessel  wall  thickness, 
although the lumen maintains its internal diameter resulting in outward expansion of the 
vessel, a process termed positive remodeling (43). The lumen gets compromised late in 
the atherosclerotic process, with the development of diffuse or focal stenosis.
Pignoli  and  colleagues  (44)  studied  in  vitro  specimens  of  human  aortic  and 
common carotid arteries to determine the anatomic structures involved in ultrasound 
energy reflection in the arterial  wall  and the feasibility measurement of arterial wall 
thickness  with  B-mode  real  time  imaging.  In  addition  to  the  invitro  studies,  these 
investigators also evaluated the common carotid arteries of 10 young volunteers in vivo 
using the same methodology.  Imaging was performed with high resolution real-time 
scanners  equipped  with  7-8  MHz  probes.  The  vessels  were  grouped  into 
macroscopically normal or with fatty streaks (class A) or vessels with atherosclerotic 
lesions (class  B).  The ultrasound pattern of class A group was characterized by two 
parallel echogenic lines separated by a hypo echoic or anechoic space. This seam pattern 
is defined as the “double line pattern”. The inner (Luminal) line was generally more 
regular,  smooth  and  thin  then  the  outer  one.  Correlating  these  findings  with  gross 
specimens, it was postulated that the inner line represents the intima, the hypo echoic 
line the media and the outer  echogenic line the adventitia.  Therefore,  measuring the 
distance from the inner echogenic line to the interface between the hypo echoic line and 
the  second  echogenic  line  represents  the  IMT  of  the  vascular  wall.  The  B-mode 
measurements of IMT showed a significant correlation with values obtained by gross 
pathology and histology in both Class A and Class B specimens. Class A aortic IMT 
measured  1.22+0.37  mm  by  gross  pathology;  and  class  B  aortic  IMT  measured 
2.06+1.02 mm versus 1.93+0.84 mm by gross pathology.
Recording of Intima media thickness
Recording of common carotid artery diameter
Intima media thickness
[ Intima media thickness measured by the distance between the thick and thin white lines (tip of 
black arrow) ]
In  early  studies  accessing  the  reproducibility  of  the  technique,  suboptimal 
performance was reported, with low intra-observer correlation coefficients (0.72-0.77) 
and poor inter-observer agreement (0.48-0.65). However, in the study by O’Leary and 
colleagues  (45),  many  technologists  from  different  centers  obtained  images  using 
various equipments,  and the images were analyzed off  line from video tape,  largely 
accounting for the high variability observed.
More recent studies demonstrate the good reproducibility of IMT measurements 
(46-48). Salonen and colleagues (46) reported an inter-observer coefficient of variations 
of 10.5 % and an inter-observer coefficient of variation of 5.4 – 5.8%. The intra-observer 
variation accounted for only 4% of the total variability, whereas the remaining 96% was 
attributable to inter-observer variables. Espeland and Colleagues (47) also examined the 
reliability  of  longitudinal  measurements  of  IMT from measurements  obtained in  the 
Asymptomatic Carotid Artery Progression Study (CAPS). These investigators concluded 
that serial IMT data were highly reliable, demonstrating the multicenter studies using B-
mode measurements are feasible and valid. It was also concluded that evaluation of the 
common carotid artery is more reproducible than the bulbous and the internal carotid 
artery, likely as a result of better visualization.
Lorenz  et  al.  (2007)  (48)  conducted  a  systematic  review  of  the  literature  to 
provide an overview of the relevant studies, critically appraise the methods used and, 
where  possible,  to  perform  a  meta-analysis  to  gain  more  robust  estimates  of  the 
predictive value of increased IMT to predict future clinical cardiovascular end points. 
The review included eight observational studies with general population based samples 
for  which  carotid  IMT  was  measured  and  follow-up  for  clinical  end  points  were 
provided. The studies represented 37,197 subjects followed for a mean of 5.5 years. The 
studies included either those that utilized mean carotid IMT, determined from a number 
of IMT measurements at specific positions or by automated software over a segment of 
the artery, and those that use maximal carotid IMT, with the Rotterdam study being the 
only one in which IMT was determined by both methods in the same population. Major 
sources  of  heterogeneity  were  age  distribution,  carotid  segment  definition  and  IMT 
measurement protocol. The review found that carotid IMT is a strong predictor of future 
vascular  events.  In  addition,  it  was  noted  that  the  relative  risk  of  increased IMT is 
slightly high risk of stroke than for MI. The analysis found that the age and sex-adjusted 
overall estimates of the relative risk of myocardial infarction were 1.26 (95% confidence 
interval  [CI],  1.21–1.30)  per  1–standard  deviation  common  carotid  artery  IMT 
difference  and  1.15  (95% CI,  1.12–1.17)  per  0.10-mm common carotid  artery  IMT 
difference. Regarding the age- and sex-adjusted relative risks of stroke, the review noted 
they were 1.32 (95% CI, 1.27–1.38) per 1–standard deviation common carotid artery 
IMT difference and 1.18 (95% CI, 1.16–1.21) per 0.10 - mm common carotid artery 
IMT difference. The review also noted heterogeneity between the studies regarding the 
details of the ultrasound protocols. These details included: the precise definitions of the 
carotid segments investigated, the use of mean or maximal IMT, the measurement of 
near and far wall or IMT, and whether IMT is measured on one side or both sides. It is 
recommended that in future studies of IMT, ultrasound protocols should be aligned with 
published studies. It appears that data for younger individuals is limited, and additional 
studies are required.
Kathiresan et al. (2007) (49) reported on a study of a stratified random sample of 
292 participants (mean age 59.5 years; 50% women) from the offspring cohort of the 
Framingham Heart Study who were free of clinically apparent cardiovascular disease. 
The authors note that screening for subclinical atherosclerosis has been advocated for 
individuals at intermediate global risk for coronary heart disease (CHD); however, the 
distribution of subclinical atherosclerosis test values across CHD risk strata is unknown. 
Abdominal and thoracic aortic plaque burden was assessed by cardiovascular magnetic 
resonance (CMR), coronary artery calcification (CAC) and thoracic aortic calcification 
(TAC)  by  electron  beam  computed  tomography  and  common  carotid  intima-media 
thickness  (CIMT)  by  ultrasonography.  The  upper  20%  of  each  measurement  was 
classified  as  a  high level  of  atherosclerosis  and then these  variables  were evaluated 
across clinically  relevant  Framingham CHD risk score strata (low, intermediate,  and 
high risk). In age adjusted analysis in men and women, correlations across CMR aortic 
plaque, CAC, TAC, and CIMT were low (maximum r=0.30 for CAC:TAC in women, 
p<0.005). In men and women, it was noted that the proportion of subjects with high 
atherosclerosis test results for any of these measurements increased significantly across 
the Framingham CHD risk score strata (Kruskal-Wallis test, p<0.0001). Regarding the 
intermediate Framingham CHD risk score category, 14% of men and 25% of women had 
a  high  atherosclerosis  result  on  ¡Ý  2  measurements.  It  was  noted  that  different 
participants  were  identified  as  having  high  atherosclerosis  by  each  modality.  For 
example, in a comparison of the overlap across CMR aortic plaque, CAC, and CIMT, 
only 4% of men and 16% of women were classified as having high atherosclerosis on all 
three  measurements.  The  authors  concluded  that  correlations  among  subclinical 
atherosclerosis  test  results  are  low,  and  a  substantial  proportion  has  high  levels  of 
subclinical atherosclerosis detected on >= 2 imaging tests.
Application of Carotid Intimal Media thickness:
Using B-mode ultrasound imaging, Howard and Colleagues (50) examined the 
incidence of carotid atherosclerosis in the general population. The median wall thickness 
ranged from 0.5 – 1 mm at all ages, with more than 5% of the cohort having carotid wall 
thickness more than 2 mm. Cross-sectional analysis suggested that age-related increases 
in wall thickness averaged approx 0.015 mm per year in women and 0.018 mm per year 
in men at the carotid bifurcation, 0.010 per year in women and 0.014 per year in men at 
the internal carotid artery, and 0.010 mm per year in both genders at the common carotid 
artery.
The association of CIMT with conventional risk factors for the atherosclerosis, 
including diabetes, hyperglycemia and fasting insulin, but also body mass index, waist 
to hip circumference ratio, and physical inactivity has been reported (50). Abdominal 
adiposity physical inactivity and abnormal glucose metabolism are associated positively 
with carotid IMT, in line with their believed contribution to atherogenesis. Similarly, the 
atherosclerosis risk in communities (ARIC) study showed that wall thickness is strongly 
associated with atherogenesic lipids, tobacco smoking and hypertension (50), suggesting 
that the atherosclerotic process is reflected in the IMT measurements.
The prognostic value of IMT has been prospectively evaluated and in multiple 
studies, increased IMT has been shown to be associated with increased cardiovascular 
morbidity (incidence of stroke and myocardial infarction) (51-55). In a study involving 
more than 4400 subjects from the Cardiovascular Health Study with age over 65 years 
and no known CVD, IMT was a predictor of new stroke or heart attack, even adjusting 
for traditional cardiovascular risk factors (55).
MATERIALS AND METHODS
Retrospective case control study 
Study Interval: April 2008 to December 2008. 
Population: 
A random sample  of  100 type  2  diabetes  patients  selected,  50 without  macro 
vascular complications and 50 with macro vascular complications.
OBJECTIVE:
1. To  compare  the  carotid  intima  media  thickness  in  control  group  and  in 
diseased population.
2. To  find  the  association  of  increased  carotid  intima  media  thickness  and 
CAHD/CVA
3. To  assess  the  usage  of  carotid  intima  media  thickness  as  a  predictor  of 
macrovascular complications in type 2 Diabetics of South India.
RESEARCH METHODOLOGY:
METHOD OF STUDY:
1. Informed consent obtained from patient.
2. Fasting and post prandial Blood sugar.
3. Body weight to nearest 0.5 kg.
4. Height to nearest 0.5 cm.
5. Blood pressure in sitting posture after 5 to 10 min of rest.
6. Circumference around the waist (Umbilical level) and hips (Greater trochanter 
level) – Waist hip ratio.
7. CAHD/CVD  Diagnosis  through  medical  history,  clinical  examination  and 
appropriate investigation including Electrocardiogram, Echo Cardiograms, and 
Computer Tomography scan.
8. Lipid profile.
9. Intima media study using high resolution B-Mode. Ultra sonogram/Doppler 
RESEARCH DESIGN Retrospective case control study
STUDY INTERVAL April 2008 to December 2008
POPULATION Adult population of age 35 to 75 with Type 2
TARGET 
POPULATION
Those with type 2 diabetes mellitus of South India
ACCESSIBLE 
POPULATION
Adult population of age 35 to 75 with Type 2 Diabetes 
attending  Coimbatore  Medical  College  Hospital  for 
Medical Care
SAMPLE SIZE 100
Ultra sonogram. 50 of the subjects matched by age, sex and BMI with type 2 
diabetes  mellitus  with  no  evidence  of  Cardio  Vascular/Cerebro  Vascular 
disease are recruited as control.
ANALYSIS:
Analysis of the data obtained by the above said study is planned to be done 
by calculating Odds ratio.
RESULTS
Demographic Profile
Age Distribution of Control and Study Population
Table-1 A
Age (years) Control group Case group
<40 1 4
41 - 59 27 28
>60 22 18
Chart – 1 A
Sex Distribution of Control and Case Group
Table -1B
Sex Control group Case group
Male 32 37
Female 18 13
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Distribution of macro vascular disease in case group
Table-2
Clinical status No of patients
Cerebro vascular disease 18
Cardio vascular disease 23
Peripheral vascular disease 9
Chart – 2
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Correlation of Glycemic level and macro vascular complications
Table-3
Post – prandial blood 
sugar (in mg/dl)
No. of patients with macrovascular 
complications
Percentage
150-200 1 2%
201-250 5 10%
251-300 10 20%
301-350 22 44%
351-400 12 24%
Chart – 3
Correlation between Cholesterol level and macro vascular complications
Table- 4
Cholesterol level (mg/dl) No of cases
150-200 10
201-239 12
240-300 16
301-350 7
350 and above 5
Chart – 4
Distribution of Carotid Intima Media thickness
in Case Group
Chart – 5
Correlation between the post prandial blood sugar levels and 
carotid intima media thickness
Table- 5
Post – prandial  
blood sugar
(in mg/dl)
Carotid intima media thickness
0.06 - 0.079 0.08 - 0.099 0.100 - 0.119
150-200 1
201-250 1 1 3
251-300 5 5
301-350 0 10 12
351-400 0 6 6
150-200 1
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Carotid Intima Media thickness in Control Group without macro 
vascular complications
Table - 6
Range No of patients
0.05 - 0.059 9
0.06 - 0.79 19
0.08 - 0.99 21
0.100 – 0.119 1
Chart – 7
Carotid Intima Media thickness in Case Group with macro 
vascular complications
Table - 7
CMT in Case Group No of cases
0.06 - 0.079 2
0.08 - 0.099 22
0.100 - 0.119 26
Chart – 8
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ANALYSIS:
Analysis of the data obtained by the above said study is done by calculating 
Odds ratio using SPSS Version 16.0.1.
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DISCUSSION
The identification of arterial wall changes in asymptomatic subjects indicates the 
need for  more strict  control  of  macrovascular  risk factors,  seeking to  prevent future 
macrovascular events.
Population and hospital based studies using non-invasive techniques to evaluate 
early changes in the structure and function of the arterial wall, such as the measurement 
of  intima  media  wall  thickness,  investigation  of  endothelial  dysfunction  and 
macrovascular calcification (63, 64, and 65) have been employed for the purpose. 
Studies determined 0.8 mm as the reference values for early thickening of the 
intima media complex associated with an increase in macrovascular risk (54, 66-69). 
Grook et  al  conducted  a  study with 315 patients  with familial  hypercholesterolemia 
compared 118 controls and showed that an intima media thickening of up to 0.8 mm 
would be considered normal.
The  present  study  shows  that  even  asymptomatic  patients  with  T2DM  has 
increased  carotid  IMT value  and  the  risk  of  acquiring  macro  vascular  combination 
increase as IMT value increases.
This study shows that increasing CIMT is strongly associated with macrovascular 
disease. In the present study we used mean aggregate IMT of the extra cranial arteries 
(altogether 6 sites at each common carotid artery, the bifurcation and the internal carotid 
artery)  including thickness of  plaque lesion,  with a view to evaluate  the association 
between macrovascular status and grade of carotid atherosclerosis. Mean IMT aggregate 
has been accessed in many previous studies, although in same of them it proved difficult 
to  evaluate  internal  carotid  intima  media  thickness  precisely  (50,  59).  However, 
technological  advancement  in  ultrasound  equipment  and  the  availability  of  high 
resolution transducer has allowed more accurate evaluation of arterial wall structure in 
past decade.
The  present  study  showed  carotid  artery  IMT  was  higher  in  patients  with 
macrovascular  complication  in  T2DM  than  in  patients  without  macrovascular 
complications in T2DM. Thickening of the mean aggregate intima media complex just 
over 1 mm may prove to the predictive of significant macrovascular disease in nearly 
95% of the patients.
The study observations are consistent with several previous studies Crouse et al 
(58) found a strong correlation between macrovascular disease and increased IMT in 
carotid  artery  diseases.  Likewise,  in  my  study  mean  aggregate  IMT increases  with 
advancing macrovascular disease.
Other  investigators  carried  out  population  based  studies  in  which  IMT  was 
evaluated  with  regard  to  the  number  and  incidence  of  stroke  or  acute  coronary 
syndromes (60). A strong association between IMT and risk of stroke and myocardial 
infection  was  established  in  Rotterdam  study  (60).  Bots  et  al  (53)  used  B  mode 
ultrasonography  to  study  the  carotid  arteries  of  7983  patients  aged  over  55  years. 
Throughout 4.6 years of observation they registered 194 new myocardial infections in 
the study going patients who has myocardial infarction had significantly higher IMT 
than others.
Furthermore, O’ leary et al (55) having examined over 5800 patients (>65 years) 
with high resolution ultrasonography found increased IMT of carotid arteries directly 
associated with increased risk of myocardial infarction and stroke.
Since,  both  the  sensitivity  and  specificity  of  Treadmill  testing  and 
Echocardiography  are  limited;  the  introduction  of  IMT measurements  of  the  carotid 
arteries may contribute significantly to diagnose the status of patients. In these patients 
high  aggregated  IMT in  carotid  arteries  may  be  adhesive  factor  in  introduction  of 
effective  medical  treatment  such  as  statins  and  antihypertensive  drugs  along  with 
effective blood sugar control.
IMT may be  considered as  another  risk  factor  for  CAD, in  the same way of 
Diabetes, hypertension according to recommendations of European society of cardiology 
publications 2000.
The non-invasive assessment of common carotid intima media thickness appears 
to provide a promising method of study of atherosclerosis directly at the level of vessel 
in population at large. The use of carotid intima media thickness measurements as an 
indicator of generalized atherosclerosis is conditioned on the view that its measurement 
reflects on macrovascular disease risk.
CONCLUSION
In conclusion, the present studies based on short follow up periods:
1. Even  in  asymptomatic  type  2  diabetic  patients  have  increased  carotid  intima 
media thickness.
2. An  increase  in  carotid  intima  media  thickness  strongly  goes  in  hand  with 
macrovascular complications.
3. Intima media thickness measurement has an intermediate or proxy end point in 
observational and interventional study.
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1 Mrs P 54 2 2 CVA No Yes Yes No No NV 76 120/80 N N No N 186 260 251-300 354 116 28 118 Ishaemia 0.096
2 Mr L 66 3 1 ACS No Yes No Yes No V 74 150/100 N N No N 170 302 301-350 360 121 23 123 ASMI 0.116
3 Mr S 45 2 1 ACS No Yes No Yes Yes NV 80 148/96 OW N Yes N 190 360 351-400 202 150 30 135 AWMI 0.093
4 Mr M 35 1 1 ACS No Yes Yes No No V 98 120/82 OW N No N 200 310 301-350 246 146 35 133 AWMI 0.093
5 Mr J 60 3 1 CVA No No Yes Yes Yes NV 74 116/80 N N Yes N 172 278 251-300 304 124 24 122 IWMI 0.096
6 Mr V 65 3 1 CVA No No No Yes Yes NV 72 120/80 N N No N 180 298 251-300 252 136 38 128 Normal 0.113
7 Mrs K 50 2 2 PVD Yes No No No No V 74 130/70 N N No H 170 364 351-400 158 82 16 88 Ishaemia 0.08
8 Mrs L 54 2 2 ACS Yes Yes No No No NV 74 160/100 OW N No N 186 400 351-400 206 148 36 134 AWMI 0.093
9 Mr A 47 2 1 ACS No No No No No V 74 120/84 OW N No N 164 307 301-350 352 118 24 119 AWMI 0.096
10 Mr R 65 3 1 CVA No No Yes Yes Yes NV 80 158/94 N N No N 190 168 150-200 168 166 26 98 Ishaemia 0.078
11 Mr G 37 1 1 ACS Yes No No No Yes NV 74 170/100 OW N No H 208 304 301-350 306 126 25 123 HLWMI 0.096
12 Mr N 52 2 1 PVD Yes No Yes No Yes NV 78 160/94 N N No N 275 314 301-350 217 115 75 147 Normal 0.096
13 Mr A 55 2 1 CVA Yes Yes No No No V 82 160/100 N N No N 180 274 251-300 252 136 38 128 Ishaemia 0.113
14 Mrs D 56 2 2 ACS No No No No No V 86 170/100 OW N No N 140 248 201-250 204 184 46 153 AWMI 0.078
15 Mr S 56 2 1 ACS No Yes Yes Yes Yes NV 84 120/80 OW N No N 198 209 201-250 246 160 38 141 AWMI 0.094
16 Mrs R 61 3 2 ACS Yes Yes No No No NV 80 160/90 OW N No N 160 306 301-350 204 188 37 155 IWMI 0.1
17 Mr V 42 2 1 CVA No No No No Yes NV 64 170/100 OW N Yes N 206 360 351-400 302 128 24 124 Ishaemia 0.116
18 Mrs J 55 2 2 CVA Yes Yes Yes No No V 76 160/90 OW N No N 190 398 351-400 302 130 30 125 Ishaemia 0.083
19 Mr S 63 3 1 PVD No No No No No V 74 150/90 N N No H 200 364 351-400 352 114 28 117 Normal 0.09
20 Mr N 65 3 1 PVD No No No Yes Yes NV 76 150/100 OW N No H 210 307 301-350 246 160 38 114 Ishaemia 0.113
21 Mr L 78 3 1 CVA No No Yes Yes No V 78 110/70 N N No N 180 368 351-400 354 116 28 118 Normal 0.096
22 Mrs M 40 1 2 CVA No No No No No NV 84 120/80 OW N No N 188 216 201-250 240 162 37 142 Normal 0.106
23 Mr T 57 2 1 ACS Yes No Yes No No V 86 160/100 OW N No N 162 304 301-350 304 124 24 122 AWMI 0.1
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39 Mr S 52 2 1 ACS No No No No No V 72 160/90 N N No N 220 316 301-350 240 154 36 138 ASMI 0.096
40 Mr R 58 2 1 ACS No No No No Yes NV 74 120/80 OW N No N 184 384 351-400 209 109 37 139 IWMI 0.113
41 Mrs S 46 2 2 CVA No No Yes No No V 70 120/74 OW N No N 164 280 251-300 200 96 28 130 Ishaemia 0.09
42 Mr M 54 2 1 CVA No No No No Yes NV 74 130/80 N N No N 156 270 251-300 195 91 23 132 Ishaemia 0.096
43 Mrs M 51 2 2 ACS No No No No No V 72 120/80 OW N No N 170 263 251-300 260 109 36 139 AWMI 0.113
44 Mr A 62 3 1 ACS Yes Yes No Yes No V 74 110/70 N N No N 160 218 201-250 306 190 40 157 IWMI 0.116
45 Mr RR 55 2 1 PVD No Yes Yes Yes Yes NV 70 130/90 N N No H 168 302 301-350 318 200 36 162 Normal 0.093
46 Mr R 52 2 1 PVD Yes No Yes No Yes NV 78 120/80 OW N No N 210 316 301-350 280 186 32 181 Normal 0.09
47 Mrs C 60 3 2 ACS Yes No No No No V 75 130/100 OW N Yes N 172 312 301-350 218 162 18 100 AWMI 0.116
48 Mr A 58 2 1 ACS Yes No No No No NV 78 130/80 OW N No N 166 308 301-350 171 160 29 101 HLWMI 0.096
49 Mr M 42 2 1 ACS No Yes No No No V 74 130/100 N N No N 180 210 201-250 202 150 40 135 IWMI 0.11
50 Mr J 72 3 1 ACS No Yes Yes Yes Yes NV 70 120/80 N N No N 190 290 251-300 174 158 32 106 IWMI 0.116
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16
3 29 132 N 0.07
10 Mrs E 52 2 F T2DM No Yes No No No NV 74 130/80 N N No H 190 206 180
14
2 43 87 N 0.076
11 Mr M 56 2 M T2DM No Yes No Yes Yes NV 72 150/80 N N No N 146 190 186 116 44 116 N 0.09
12 Mr K 54 2 M T2DM No Yes No No No NV 84 160/90 N N No N 195 265 187 115 39 121 N 0.08
13 Mr F 60 3 M T2DM No No No No No NV 80 120/70 N N No N 184 260 180
13
9 46 112 N 0.08
14 Mrs P 50 2 F T2DM No No No No No NV 70 130/70 N N No N 260 402 159 85 34 89 N 0.078
15 Mr J 65 3 M T2DM No No No No No V 82 120/70 N N No N 230 216 192
12
8 24 96 N 0.09
16 Mr K 50 2 M T2DM No No No Yes Yes NV 74 160/80 N N No N 242 307 180
13
2 42 134 N 0.06
17 Mr N 56 2 M T2DM/SHT Yes Yes No No No NV 76 140/100 N N No N 290 306 167 115 26 119 N 0.083
18 Mrs T 55 2 F T2DM No No No No No NV 70 110/70 N N No N 202 362 153 98 24 113 N 0.076
19 Mrs A 60 3 F T2DM No No No No No NV 78 120/80 OW N No N 210 350 203
16
0 24 136 N 0.068
20 Mr V 66 3 M T2DM No No No Yes Yes V 68 130/80 N N No N 294 360 220
13
4 42 151 N 0.076
21 Mr P 60 3 M T2DM No Yes No No No NV 70 140/80 N N No N 216 320 196
14
5 39 124 N 0.083
22 Mr R 55 2 M T2DM No Yes No Yes No NV 72 130/60 N N No N 240 394 205 16 25 131 N 0.082
223 Mrs K 63 3 F T2DM No No No No No NV 76 110/74 N N No N 220 296 182
12
4 29 142 N 0.078
24 Mr M 52 2 M T2DM No No No Yes Yes V 70 100/80 N N No N 212 304 195 116 32 98 N 0.068
25 Mrs S 60 3 F T2DM/SHT Yes Yes No No No V 74 118/70 N N No N 230 310 240
16
8 34 140 N 0.09
26 Mr A 60 3 M T2DM No No No Yes No NV 80 140/80 OW N No N 210 356 192 113 38 114 N 0.082
27 Mr P 63 3 M T2DM/SHT Yes Yes No No No NV 82 130/100 N N No N 202 341 254
19
0 24 130 N 0.11
28 Mr K 56 2 M T2DM No No No Yes Yes NV 86 118/90 OW N No N 198 240 215
14
8 32 100 N 0.083
29 Mrs R 43 2 F T2DM No No No No No NV 70 130/60 N N No N 164 300 218
16
2 26 119 N 0.054
30 Mr A 50 2 M T2DM No No No Yes No NV 72 110/70 N N No H 190 260 205
16
5 30 124 N 0.068
31 Mr I 55 2 M T2DM No No No No No NV 78 116/80 N N No N 162 204 195
15
2 32 112 N 0.078
32 Mr P 56 2 M T2DM No No No No No NV 76 130/70 OW N No N 169 226 208
16
0 28 96 N 0.068
33 Mr S 60 3 M T2DM/SHT Yes Yes No Yes No NV 70 130/80 N N No N 170 195 205
14
2 21 134 N 0.093
34 Mrs P 47 2 F T2DM No No No No No NV 74 140/80 N N No N 148 254 182
12
9 30 112 N 0.072
35 Mr L 50 2 M T2DM No No No Yes No V 80 110/70 N N No N 160 320 220
16
4 25 132 N 0.078
36 Mr V 50 2 M T2DM No No No No No NV 82 120/70 N N No N 224 360 200
13
2 36 98 N 0.056
37 Mr C 66 3 M T2DM No No No No Yes NV 74 130/70 OW N No N 215 342 216
14
7 23 120 N 0.083
38 Mrs S 55 2 F T2DM No Yes No No No V 68 118/84 N N No N 200 264 255
18
6 40 132 N 0.086
39 Mrs A 53 2 F T2DM No No No No No NV 65 116/80 N N No N 212 220 240
19
4 32 97 N 0.09
40 Mr B 60 3 M T2DM No Yes No Yes Yes NV 70 120/70 N N No N 205 280 242
16
8 28 120 N 0.078
41 Mrs L 50 2 F T2DM No Yes No No No NV 72 110/80 N N No N 168 226 194
13
2 40 89 N 0.056
42 Mr G 45 2 M T2DM No Yes No No Yes NV 78 120/70 N N No N 196 234 248
16
8 32 140 N 0.053
43 Mr P 55 2 M T2DM/SHT Yes No No Yes Yes NV 76 130/90 N N No N 204 234 216
14
4 30 124 N 0.086
44 Mrs K 62 3 F T2DM No No No No No NV 72 140/90 OW N No N 261 402 160 98 27 94 N 0.058
45 Mr S 60 3 M T2DM No No No Yes Yes V 78 130/80 N N No N 240 264 190 112 32 98 N 0.086
46 Mrs R 59 2 F T2DM No No No No No V 70 110/70 N N No N 230 194 215
16
4 48 148 N 0.068
47 Mrs C 60 3 F T2DM No Yes No No No V 72 120/70 N N No N 210 220 185 116 30 100 N 0.058
48 Mr K 62 3 M T2DM No No No Yes Yes NV 70 130/84 N N No N 200 232 245
16
8 32 114 N 0.09
49 Mr L 60 3 M T2DM No No No No No V 76 110/70 N N No N 212 200 140
10
0 22 96 N 0.082
50 Mr P 60 3 M T2DM No No No No No NV 80 100/80 N N No N 164 225 190
14
6 24 99 N 0.078

